News Roundup: Physician-Pharmacist Collaboration Can Improve Diabetes Outcomes, Plus More Coverage of ADA 2021

Here’s a roundup of the latest news coverage from Drug Topics®.

Don’t waste time digging through articles to find the most up-to-date and important news. Drug Topics® has you covered with our weekly news roundup of the latest pharmacy-related news you should know before the weekend begins.

Here’s a roundup of the latest news coverage from Drug Topics®.

Education Can Help Mitigate Parental Concern Over Flu Vaccination for Children With Diabetes

Educating families to alleviate fear in pediatric populations regarding the flu vaccine will improve the vaccination rate and protect high-risk children. Due to the negative effects of the flu in children with diabetes, it is vital that at-risk youth be vaccinated.

Read more

Blood Glucose Levels Not A Significant Predictor of Death for ICU Patients With COVID-19

Study results showed there was no significant correlation between blood glucose levels and mortality or the rate of stay in intensive care units of hospitals for sick patients with diabetes, pneumonia, and COVID-19.

Read more

Shingles Vaccination Rate Surpasses US Target Goal

Rates for other vaccinations remain low in the United States.

Read more

Metformin May Improve Cardiovascular Function in Adolescents With Type 1 Diabetes

At the virtual Scientific Sessions for the American Diabetes Association, a study shows that metformin can improve adolescent type 1 diabetes.

Read more

Physician-Pharmacist Collaboration Can Improve Diabetes Outcomes in Rural Populations

A poster presented at the American Diabetes Association Virtual 81st Scientific Sessions highlighted the effect of a physician-pharmacist collaborative management team in diabetes preventative care services.

Read more

New Diversity Policy Adopted By American Medical Association

The policy is part of the organization’s commitment to racial justice and equity.

Read more on Contemporary Pediatrics.

Third COVID-19 Jab May Be Needed for Patients With Advanced Liver Disease

The Pfizer COVID-19 vaccine confers low immunity on people with advanced liver disease, so a third booster shot may be needed, according to research presented at the 2021 International Liver Congress in Geneva, Switzerland, which was held from June 23-26.

Read more